Spurred by Survivors, Researchers Are Revisiting Cancer Drug Doses

https://www.cancer.gov/news-events/cancer-currents-blog/2024/cancer-drugs-lower-doses?cid=eb_govdel When it comes to cancer drugs, researchers are moving away from a paradigm called the maximum tolerated dose. Instead, they’re focusing more on identifying doses that produce fewer side effects but are still effective against a person’s cancer.